Global Quetiapine Fumarate Market Insights and Forecast to 2027

Publisher Name :
Date: 19-May-2021
No. of pages: 113
Inquire Before Buying

Quetiapine Fumarate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Quetiapine Fumarate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Immediate Release Tablets

- Extended Release Tablets

Segment by Application

- Adult

- Others

By Company

- AstraZeneca

- Intas

- TAPI

- Accord

- Hexal

- Dr.Reddy's

- Lupin

- Sun Pharmaceutical

- Hunan Dongting Pharm

- SuZhou NO.4 Phamaceutical Factory

- Fuan Pharmaceutical

- Zhejiang Supor Pharmaceuticals

- Zhejiang Huahai Pharmaceutical

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Quetiapine Fumarate Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Quetiapine Fumarate Product Introduction
1.2 Market by Type
1.2.1 Global Quetiapine Fumarate Market Size Growth Rate by Type
1.4.2 Immediate Release Tablets
1.4.3 Extended Release Tablets
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Market Size Growth Rate by Application
1.3.2 Adult
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Quetiapine Fumarate Sales Estimates and Forecasts 2016-2027
2.2 Global Quetiapine Fumarate Revenue Estimates and Forecasts 2016-2027
2.3 Global Quetiapine Fumarate Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Quetiapine Fumarate Regions by Sales
2.4.1 Global Top Quetiapine Fumarate Regions by Sales (2016-2021)
2.4.2 Global Top Quetiapine Fumarate Regions by Sales (2022-2027)
2.5 Global Top Quetiapine Fumarate Regions by Revenue
2.5.1 Global Top Quetiapine Fumarate Regions by Revenue (2016-2021)
2.5.2 Global Top Quetiapine Fumarate Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Quetiapine Fumarate Sales by Manufacturers
3.1.1 Global Top Quetiapine Fumarate Manufacturers by Sales (2016-2021)
3.1.2 Global Top Quetiapine Fumarate Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Quetiapine Fumarate Sales in 2020
3.2 Global Quetiapine Fumarate Revenue by Manufacturers
3.2.1 Global Top Quetiapine Fumarate Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Quetiapine Fumarate Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Quetiapine Fumarate Revenue in 2020
3.3 Global Quetiapine Fumarate Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Quetiapine Fumarate Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Quetiapine Fumarate Sales by Type
4.1.1 Global Quetiapine Fumarate Historical Sales by Type (2016-2021)
4.1.2 Global Quetiapine Fumarate Forecasted Sales by Type (2022-2027)
4.1.3 Global Quetiapine Fumarate Sales Market Share by Type (2016-2027)
4.2 Global Quetiapine Fumarate Revenue by Type
4.2.1 Global Quetiapine Fumarate Historical Revenue by Type (2016-2021)
4.2.2 Global Quetiapine Fumarate Forecasted Revenue by Type (2022-2027)
4.2.3 Global Quetiapine Fumarate Revenue Market Share by Type (2016-2027)
4.3 Global Quetiapine Fumarate Price by Type
4.3.1 Global Quetiapine Fumarate Price by Type (2016-2021)
4.3.2 Global Quetiapine Fumarate Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Quetiapine Fumarate Sales by Application
5.1.1 Global Quetiapine Fumarate Historical Sales by Application (2016-2021)
5.1.2 Global Quetiapine Fumarate Forecasted Sales by Application (2022-2027)
5.1.3 Global Quetiapine Fumarate Sales Market Share by Application (2016-2027)
5.2 Global Quetiapine Fumarate Revenue by Application
5.2.1 Global Quetiapine Fumarate Historical Revenue by Application (2016-2021)
5.2.2 Global Quetiapine Fumarate Forecasted Revenue by Application (2022-2027)
5.2.3 Global Quetiapine Fumarate Revenue Market Share by Application (2016-2027)
5.3 Global Quetiapine Fumarate Price by Application
5.3.1 Global Quetiapine Fumarate Price by Application (2016-2021)
5.3.2 Global Quetiapine Fumarate Price Forecast by Application (2022-2027)
6 North America
6.1 North America Quetiapine Fumarate Market Size by Type
6.1.1 North America Quetiapine Fumarate Sales by Type (2016-2027)
6.1.2 North America Quetiapine Fumarate Revenue by Type (2016-2027)
6.2 North America Quetiapine Fumarate Market Size by Application
6.2.1 North America Quetiapine Fumarate Sales by Application (2016-2027)
6.2.2 North America Quetiapine Fumarate Revenue by Application (2016-2027)
6.3 North America Quetiapine Fumarate Market Size by Country
6.3.1 North America Quetiapine Fumarate Sales by Country (2016-2027)
6.3.2 North America Quetiapine Fumarate Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Quetiapine Fumarate Market Size by Type
7.1.1 Europe Quetiapine Fumarate Sales by Type (2017-2027)
7.1.2 Europe Quetiapine Fumarate Revenue by Type (2017-2027)
7.2 Europe Quetiapine Fumarate Market Size by Application
7.2.1 Europe Quetiapine Fumarate Sales by Application (2017-2027)
7.2.2 Europe Quetiapine Fumarate Revenue by Application (2017-2027)
7.3 Europe Quetiapine Fumarate Market Size by Country
7.3.1 Europe Quetiapine Fumarate Sales by Country (2017-2027)
7.3.2 Europe Quetiapine Fumarate Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Quetiapine Fumarate Market Size by Type
8.1.1 Asia Pacific Quetiapine Fumarate Sales by Type (2018-2027)
8.1.2 Asia Pacific Quetiapine Fumarate Revenue by Type (2018-2027)
8.2 Asia Pacific Quetiapine Fumarate Market Size by Application
8.2.1 Asia Pacific Quetiapine Fumarate Sales by Application (2018-2027)
8.2.2 Asia Pacific Quetiapine Fumarate Revenue by Application (2018-2027)
8.3 Asia Pacific Quetiapine Fumarate Market Size by Region
8.3.1 Asia Pacific Quetiapine Fumarate Sales by Region (2018-2027)
8.3.2 Asia Pacific Quetiapine Fumarate Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Quetiapine Fumarate Market Size by Type
9.1.1 Latin America Quetiapine Fumarate Sales by Type (2019-2027)
9.1.2 Latin America Quetiapine Fumarate Revenue by Type (2019-2027)
9.2 Latin America Quetiapine Fumarate Market Size by Application
9.2.1 Latin America Quetiapine Fumarate Sales by Application (2019-2027)
9.2.2 Latin America Quetiapine Fumarate Revenue by Application (2019-2027)
9.3 Latin America Quetiapine Fumarate Market Size by Country
9.3.1 Latin America Quetiapine Fumarate Sales by Country (2019-2027)
9.3.2 Latin America Quetiapine Fumarate Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Quetiapine Fumarate Market Size by Type
6.1.1 Middle East and Africa Quetiapine Fumarate Sales by Type (2016-2027)
6.1.2 Middle East and Africa Quetiapine Fumarate Revenue by Type (2016-2027)
6.2 Middle East and Africa Quetiapine Fumarate Market Size by Application
6.2.1 Middle East and Africa Quetiapine Fumarate Sales by Application (2016-2027)
6.2.2 Middle East and Africa Quetiapine Fumarate Revenue by Application (2016-2027)
6.3 Middle East and Africa Quetiapine Fumarate Market Size by Country
6.3.1 Middle East and Africa Quetiapine Fumarate Sales by Country (2016-2027)
6.3.2 Middle East and Africa Quetiapine Fumarate Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AstraZeneca Quetiapine Fumarate Product Description
11.1.5 AstraZeneca Related Developments
11.2 Intas
11.2.1 Intas Corporation Information
11.2.2 Intas Overview
11.2.3 Intas Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Intas Quetiapine Fumarate Product Description
11.2.5 Intas Related Developments
11.3 TAPI
11.3.1 TAPI Corporation Information
11.3.2 TAPI Overview
11.3.3 TAPI Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 TAPI Quetiapine Fumarate Product Description
11.3.5 TAPI Related Developments
11.4 Accord
11.4.1 Accord Corporation Information
11.4.2 Accord Overview
11.4.3 Accord Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Accord Quetiapine Fumarate Product Description
11.4.5 Accord Related Developments
11.5 Hexal
11.5.1 Hexal Corporation Information
11.5.2 Hexal Overview
11.5.3 Hexal Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Hexal Quetiapine Fumarate Product Description
11.5.5 Hexal Related Developments
11.6 Dr.Reddy's
11.6.1 Dr.Reddy's Corporation Information
11.6.2 Dr.Reddy's Overview
11.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Dr.Reddy's Quetiapine Fumarate Product Description
11.6.5 Dr.Reddy's Related Developments
11.7 Lupin
11.7.1 Lupin Corporation Information
11.7.2 Lupin Overview
11.7.3 Lupin Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Lupin Quetiapine Fumarate Product Description
11.7.5 Lupin Related Developments
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Corporation Information
11.8.2 Sun Pharmaceutical Overview
11.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Description
11.8.5 Sun Pharmaceutical Related Developments
11.9 Hunan Dongting Pharm
11.9.1 Hunan Dongting Pharm Corporation Information
11.9.2 Hunan Dongting Pharm Overview
11.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Description
11.9.5 Hunan Dongting Pharm Related Developments
11.10 SuZhou NO.4 Phamaceutical Factory
11.10.1 SuZhou NO.4 Phamaceutical Factory Corporation Information
11.10.2 SuZhou NO.4 Phamaceutical Factory Overview
11.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Description
11.10.5 SuZhou NO.4 Phamaceutical Factory Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AstraZeneca Quetiapine Fumarate Product Description
11.1.5 AstraZeneca Related Developments
11.12 Zhejiang Supor Pharmaceuticals
11.12.1 Zhejiang Supor Pharmaceuticals Corporation Information
11.12.2 Zhejiang Supor Pharmaceuticals Overview
11.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Zhejiang Supor Pharmaceuticals Product Description
11.12.5 Zhejiang Supor Pharmaceuticals Related Developments
11.13 Zhejiang Huahai Pharmaceutical
11.13.1 Zhejiang Huahai Pharmaceutical Corporation Information
11.13.2 Zhejiang Huahai Pharmaceutical Overview
11.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Zhejiang Huahai Pharmaceutical Product Description
11.13.5 Zhejiang Huahai Pharmaceutical Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Quetiapine Fumarate Value Chain Analysis
12.2 Quetiapine Fumarate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Quetiapine Fumarate Production Mode & Process
12.4 Quetiapine Fumarate Sales and Marketing
12.4.1 Quetiapine Fumarate Sales Channels
12.4.2 Quetiapine Fumarate Distributors
12.5 Quetiapine Fumarate Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Quetiapine Fumarate Industry Trends
13.2 Quetiapine Fumarate Market Drivers
13.3 Quetiapine Fumarate Market Challenges
13.4 Quetiapine Fumarate Market Restraints
14 Key Findings in The Global Quetiapine Fumarate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Quetiapine Fumarate Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Immediate Release Tablets
Table 3. Major Manufacturers of Extended Release Tablets
Table 4. Global Quetiapine Fumarate Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Quetiapine Fumarate Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Quetiapine Fumarate Sales by Region (2016-2021) & (MT)
Table 7. Global Quetiapine Fumarate Sales Market Share by Region (2016-2021)
Table 8. Global Quetiapine Fumarate Sales by Region (2016-2021) & (MT)
Table 9. Global Quetiapine Fumarate Sales Market Share by Region (2022-2027)
Table 10. Global Quetiapine Fumarate Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Quetiapine Fumarate Revenue Market Share by Region (2016-2021)
Table 12. Global Quetiapine Fumarate Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Quetiapine Fumarate Revenue Market Share by Region (2022-2027)
Table 14. Global Quetiapine Fumarate Sales by Manufacturers (2016-2021) & (MT)
Table 15. Global Quetiapine Fumarate Sales Share by Manufacturers (2016-2021)
Table 16. Global Quetiapine Fumarate Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Quetiapine Fumarate Revenue Share by Manufacturers (2016-2021)
Table 18. Quetiapine Fumarate Price by Manufacturers 2016-2021 (USD/Kg)
Table 19. Global Quetiapine Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Quetiapine Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quetiapine Fumarate as of 2020)
Table 21. Quetiapine Fumarate Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Quetiapine Fumarate Product Offered
Table 23. Date of Manufacturers Enter into Quetiapine Fumarate Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
Table 26. Global Quetiapine Fumarate Sales by Type (2022-2027) & (MT)
Table 27. Global Quetiapine Fumarate Sales Share by Type (2016-2021)
Table 28. Global Quetiapine Fumarate Sales Share by Type (2022-2027)
Table 29. Global Quetiapine Fumarate Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Quetiapine Fumarate Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Quetiapine Fumarate Revenue Share by Type (2016-2021)
Table 32. Global Quetiapine Fumarate Revenue Share by Type (2022-2027)
Table 33. Quetiapine Fumarate Price by Type (2016-2021) & (USD/Kg)
Table 34. Global Quetiapine Fumarate Price Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
Table 36. Global Quetiapine Fumarate Sales by Application (2022-2027) & (MT)
Table 37. Global Quetiapine Fumarate Sales Share by Application (2016-2021)
Table 38. Global Quetiapine Fumarate Sales Share by Application (2022-2027)
Table 39. Global Quetiapine Fumarate Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Quetiapine Fumarate Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Quetiapine Fumarate Revenue Share by Application (2016-2021)
Table 42. Global Quetiapine Fumarate Revenue Share by Application (2022-2027)
Table 43. Quetiapine Fumarate Price by Application (2016-2021) & (USD/Kg)
Table 44. Global Quetiapine Fumarate Price Forecast by Application (2022-2027) & (USD/Kg)
Table 45. North America Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
Table 46. North America Quetiapine Fumarate Sales by Type (2022-2027) & (MT)
Table 47. North America Quetiapine Fumarate Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Quetiapine Fumarate Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
Table 50. North America Quetiapine Fumarate Sales by Application (2022-2027) & (MT)
Table 51. North America Quetiapine Fumarate Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Quetiapine Fumarate Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
Table 54. North America Quetiapine Fumarate Sales by Country (2022-2027) & (MT)
Table 55. North America Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Quetiapine Fumarate Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
Table 58. Europe Quetiapine Fumarate Sales by Type (2022-2027) & (MT)
Table 59. Europe Quetiapine Fumarate Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Quetiapine Fumarate Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
Table 62. Europe Quetiapine Fumarate Sales by Application (2022-2027) & (MT)
Table 63. Europe Quetiapine Fumarate Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Quetiapine Fumarate Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
Table 66. Europe Quetiapine Fumarate Sales by Country (2022-2027) & (MT)
Table 67. Europe Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Quetiapine Fumarate Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
Table 70. Asia Pacific Quetiapine Fumarate Sales by Type (2022-2027) & (MT)
Table 71. Asia Pacific Quetiapine Fumarate Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Quetiapine Fumarate Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
Table 74. Asia Pacific Quetiapine Fumarate Sales by Application (2022-2027) & (MT)
Table 75. Asia Pacific Quetiapine Fumarate Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Quetiapine Fumarate Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Quetiapine Fumarate Sales by Region (2016-2021) & (MT)
Table 78. Asia Pacific Quetiapine Fumarate Sales by Region (2022-2027) & (MT)
Table 79. Asia Pacific Quetiapine Fumarate Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Quetiapine Fumarate Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
Table 82. Latin America Quetiapine Fumarate Sales by Type (2022-2027) & (MT)
Table 83. Latin America Quetiapine Fumarate Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Quetiapine Fumarate Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
Table 86. Latin America Quetiapine Fumarate Sales by Application (2022-2027) & (MT)
Table 87. Latin America Quetiapine Fumarate Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Quetiapine Fumarate Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
Table 90. Latin America Quetiapine Fumarate Sales by Country (2022-2027) & (MT)
Table 91. Latin America Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Quetiapine Fumarate Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
Table 94. Middle East and Africa Quetiapine Fumarate Sales by Type (2022-2027) & (MT)
Table 95. Middle East and Africa Quetiapine Fumarate Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Quetiapine Fumarate Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
Table 98. Middle East and Africa Quetiapine Fumarate Sales by Application (2022-2027) & (MT)
Table 99. Middle East and Africa Quetiapine Fumarate Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Quetiapine Fumarate Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
Table 102. Middle East and Africa Quetiapine Fumarate Sales by Country (2022-2027) & (MT)
Table 103. Middle East and Africa Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Quetiapine Fumarate Revenue by Country (2022-2027) & (US$ Million)
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Major Businesses
Table 107. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 108. AstraZeneca Quetiapine Fumarate Product
Table 109. AstraZeneca Recent Developments
Table 110. Intas Corporation Information
Table 111. Intas Description and Major Businesses
Table 112. Intas Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Intas Quetiapine Fumarate Product
Table 114. Intas Recent Developments
Table 115. TAPI Corporation Information
Table 116. TAPI Description and Major Businesses
Table 117. TAPI Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. TAPI Quetiapine Fumarate Product
Table 119. TAPI Recent Developments
Table 120. Accord Corporation Information
Table 121. Accord Description and Major Businesses
Table 122. Accord Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Accord Quetiapine Fumarate Product
Table 124. Accord Recent Developments
Table 125. Hexal Corporation Information
Table 126. Hexal Description and Major Businesses
Table 127. Hexal Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Hexal Quetiapine Fumarate Product
Table 129. Hexal Recent Developments
Table 130. Dr.Reddy's Corporation Information
Table 131. Dr.Reddy's Description and Major Businesses
Table 132. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Dr.Reddy's Quetiapine Fumarate Product
Table 134. Dr.Reddy's Recent Developments
Table 135. Lupin Corporation Information
Table 136. Lupin Description and Major Businesses
Table 137. Lupin Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Lupin Quetiapine Fumarate Product
Table 139. Lupin Recent Developments
Table 140. Sun Pharmaceutical Corporation Information
Table 141. Sun Pharmaceutical Description and Major Businesses
Table 142. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Sun Pharmaceutical Quetiapine Fumarate Product
Table 144. Sun Pharmaceutical Recent Developments
Table 145. Hunan Dongting Pharm Corporation Information
Table 146. Hunan Dongting Pharm Description and Major Businesses
Table 147. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 148. Hunan Dongting Pharm Quetiapine Fumarate Product
Table 149. Hunan Dongting Pharm Recent Developments
Table 150. SuZhou NO.4 Phamaceutical Factory Corporation Information
Table 151. SuZhou NO.4 Phamaceutical Factory Description and Major Businesses
Table 152. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 153. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product
Table 154. SuZhou NO.4 Phamaceutical Factory Recent Developments
Table 155. Fuan Pharmaceutical Corporation Information
Table 156. Fuan Pharmaceutical Description and Major Businesses
Table 157. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Fuan Pharmaceutical Quetiapine Fumarate Product
Table 159. Fuan Pharmaceutical Recent Developments
Table 160. Zhejiang Supor Pharmaceuticals Corporation Information
Table 161. Zhejiang Supor Pharmaceuticals Description and Major Businesses
Table 162. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product
Table 164. Zhejiang Supor Pharmaceuticals Recent Developments
Table 165. Zhejiang Huahai Pharmaceutical Corporation Information
Table 166. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 167. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product
Table 169. Zhejiang Huahai Pharmaceutical Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Quetiapine Fumarate Distributors List
Table 173. Quetiapine Fumarate Customers List
Table 174. Quetiapine Fumarate Market Trends
Table 175. Quetiapine Fumarate Market Drivers
Table 176. Quetiapine Fumarate Market Challenges
Table 177. Quetiapine Fumarate Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Quetiapine Fumarate Product Picture
Figure 2. Global Quetiapine Fumarate Market Share by Type in 2020 & 2027
Figure 3. Immediate Release Tablets Product Picture
Figure 4. Extended Release Tablets Product Picture
Figure 5. Global Quetiapine Fumarate Sales Market Share by Application in 2020 & 2027
Figure 6. Adult
Figure 7. Others
Figure 8. Quetiapine Fumarate Report Years Considered
Figure 9. Global Quetiapine Fumarate Sales 2016-2027 (MT)
Figure 10. Global Quetiapine Fumarate Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Quetiapine Fumarate Revenue 2016-2027 (US$ Million)
Figure 12. Global Quetiapine Fumarate Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Quetiapine Fumarate Sales Market Share by Region (2016-2021)
Figure 14. Global Quetiapine Fumarate Sales Market Share by Region (2022-2027)
Figure 15. North America Quetiapine Fumarate Sales YoY (2016-2027) & (MT)
Figure 16. North America Quetiapine Fumarate Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Quetiapine Fumarate Sales YoY (2016-2027) & (MT)
Figure 18. Europe Quetiapine Fumarate Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Quetiapine Fumarate Sales YoY (2016-2027) & (MT)
Figure 20. Asia-Pacific Quetiapine Fumarate Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Quetiapine Fumarate Sales YoY (2016-2027) & (MT)
Figure 22. Latin America Quetiapine Fumarate Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Quetiapine Fumarate Sales YoY (2016-2027) & (MT)
Figure 24. Middle East & Africa Quetiapine Fumarate Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Quetiapine Fumarate Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Quetiapine Fumarate Revenue in 2020
Figure 27. Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Quetiapine Fumarate Sales Market Share by Type (2016-2027)
Figure 29. Global Quetiapine Fumarate Revenue Market Share by Type (2016-2027)
Figure 30. Global Quetiapine Fumarate Sales Market Share by Application (2016-2027)
Figure 31. Global Quetiapine Fumarate Revenue Market Share by Application (2016-2027)
Figure 32. North America Quetiapine Fumarate Sales Market Share by Type (2016-2027)
Figure 33. North America Quetiapine Fumarate Revenue Market Share by Type (2016-2027)
Figure 34. North America Quetiapine Fumarate Sales Market Share by Application (2016-2027)
Figure 35. North America Quetiapine Fumarate Revenue Market Share by Application (2016-2027)
Figure 36. North America Quetiapine Fumarate Sales Share by Country (2016-2027)
Figure 37. North America Quetiapine Fumarate Revenue Share by Country (2016-2027)
Figure 38. U.S. Quetiapine Fumarate Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Quetiapine Fumarate Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Quetiapine Fumarate Sales Market Share by Type (2016-2027)
Figure 41. Europe Quetiapine Fumarate Revenue Market Share by Type (2016-2027)
Figure 42. Europe Quetiapine Fumarate Sales Market Share by Application (2016-2027)
Figure 43. Europe Quetiapine Fumarate Revenue Market Share by Application (2016-2027)
Figure 44. Europe Quetiapine Fumarate Sales Share by Country (2016-2027)
Figure 45. Europe Quetiapine Fumarate Revenue Share by Country (2016-2027)
Figure 46. Germany Quetiapine Fumarate Revenue (2016-2027) & (US$ Million)
Figure 47. France Quetiapine Fumarate Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Quetiapine Fumarate Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Quetiapine Fumarate Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Quetiapine Fumarate Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Quetiapine Fumarate Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Quetiapine Fumarate Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Quetiapine Fumarate Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Quetiapine Fumarate Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Quetiapine Fumarate Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Quetiapine Fumarate Revenue Share by Region (2016-2027)
Figure 57. China Quetiapine Fumarate Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Quetiapine Fumarate Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Quetiapine F
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs